Choice of empirical therapy and prophylaxis.
Del Favero
Albano
A
Policlinico Monteluce, Perugia, Italy.
Bucaneve
Giampaulo
G
Furno
Paolo
P
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005334:Fever / Q000209:etiology; D006801:Humans; D016867:Immunocompromised Host; D017053:Infection Control; D007239:Infections / Q000188:drug therapy*; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents